ClearPoint Neuro Inc vs ZIM Integrated Shipping Services Ltd — how do they compare? ClearPoint Neuro Inc trades at $15.75 (market cap $478.63M), while ZIM Integrated Shipping Services Ltd trades at $24.56 (market cap $2.94B). The key difference: ZIM Integrated Shipping Services Ltd is far larger — about 6.1× ClearPoint Neuro Inc's market cap, and ZIM Integrated Shipping Services Ltd pays a 20.16% dividend while ClearPoint Neuro Inc pays none. Which is the better fit depends on your goals.
| CLPT | ZIM | |
|---|---|---|
Market Cap | $478.63M | $2.94B |
Sector | Health | Industrials |
52-Week High | $29.60 | $29.27 |
52-Week Low | $8.66 | $12.44 |
Enterprise Value | $506.63M | $6.79B |
Dividend Yield | — | 20.16% |
Signals from Pluang's Aura AI — not financial advice
ClearPoint Neuro (CLPT) trades at $16.51, down 5.66% on the day, with a bullish technical signal from moving averages but negative profitability. The company reported record Q1 2026 revenue of $36.97M with 25% organic device growth, though it missed EPS estimates with a $0.32 loss. Recent FDA clearance for the Velocity Alpha surgical drill and a partnership with Sungkyunkwan University highlight expansion efforts in neurosurgical navigation and drug delivery.
Outlook remains speculative with 100% analyst buy ratings anticipating gene therapy commercialization upside, but high execution and regulatory risks persist amid consistent losses and negative margins. The stock's valuation at 11.31x sales reflects growth expectations, yet cash burn from operations requires careful monitoring of financing sustainability.
ZIM Integrated Shipping Services (ZIM) trades at $23.80, down 0.71% on the day, amid bearish technical signals and mixed fundamental performance. The stock faces pressure from regulatory setbacks to its Hapag-Lloyd merger, though recent news highlights rival takeover interest. Financially, 2025 revenue was $6.90B with net income of $479.20M, but 2026 projections show declining profitability. Analyst consensus is split evenly between Hold and Sell, with a price target of $16.75, well below current levels.
The outlook for ZIM is cautious due to merger uncertainty and weakening earnings. Investment opportunities exist if takeover bids materialize, but risks include regulatory hurdles, freight rate volatility, and cash flow pressures. The stock's current price trades at a discount to asset value, yet analyst skepticism and bearish technicals suggest limited near-term upside without positive deal developments.
Trailing returns across standard periods
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →ZIM is a global container liner shipping company that employs a 'global-niche' strategy, focusing on specific trade lanes where it holds a competitive advantage. Unlike larger, asset-heavy competitors, ZIM operates an agile, charter-intensive fleet, allowing it to rapidly adjust capacity to market demand while prioritizing digitalization and specialized cargo like refrigerated (reefer) goods.
Read more on ZIM →